COVID antibody
Scope
Date
~
-
Bio & Pharma
Samsung, Celltrion lead biosimilar market in Europe, US
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...
Mar 10, 2025 (Gmt+09:00)
-
IPOs
Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut
SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...
Jan 16, 2025 (Gmt+09:00)
-
IPOs
Sono International seeks IPO in 2025 with $2.1 billion in corporate value
South Korea’s top resort operator Sono International Co. is seeking an initial public offering of its shares on the Korean market next year, r...
Dec 05, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Remsima on course to become Korea’s 1st blockbuster drug
Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...
Nov 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to establish CDMO subsidiary
Celltrion Inc., South Korea’s largest biosimilar maker, said on Friday it plans to establish a contract development and manufacturing organiza...
Oct 18, 2024 (Gmt+09:00)
-
Korean startups
Enormous market ahead for Hopae, S.Korean DID pioneer
To Hopae Inc., a digital identity solution-developing startup native to South Korea, its home market is small. After successfully accommodating more...
Aug 22, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion eyes M&A in Europe, $3.3 bn Zymfentra sales: chairman
WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...
May 23, 2024 (Gmt+09:00)
-
Travel & Leisure
S.Korea sees record-high foreign visitors after pandemic
South Korea saw a record-high number of foreign tourists post-COVID-19 in the first quarter of 2024. The South Korean Ministry of Culture, Spor...
Apr 30, 2024 (Gmt+09:00)
-
Travel & Leisure
Number of foreign tourists visiting Korea surpasses 11 million in 2023
The number of foreign tourists visiting Korea last year exceeded 11 million, reaching 63% of the pre-COVID level, with over 1 million arrivals month...
Jan 30, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion, WuXi XDC to develop new antibody-drug conjugates
South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...
Jan 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics, NJ Bio to jointly develop ADC
South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clin...
Jan 22, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Orion to buy control of biotech startup LegoChem for $415 mn
South Korea’s snack and confectionery maker Orion Group has agreed to buy a controlling stake in LegoChem Biosciences Inc., a Korean biotech s...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience start to deliver Novavax COVID-19 vaccine
South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Cyron to develop multi-specific antibody new drug
South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...
Dec 06, 2023 (Gmt+09:00)
-
Food & Beverage
Korea Post resumes kimchi delivery to US
South Korea's state-run postal service agency Korea Post announced on Monday it resumed Express Mail Service (EMS) for shipping kimchi all over the ...
Nov 13, 2023 (Gmt+09:00)
-
Bio & Pharma
'World-class bispecific antibody technology of ABL Bio'
MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...
Nov 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte builds US antibody-drug conjugate plant with $82 mn
South Korea’s Lotte Biologics Co. is establishing an antibody-drug conjugate (ADC) factory in Syracuse, New York, with an investment of 110 bi...
Oct 31, 2023 (Gmt+09:00)
-
Travel & Leisure
S.Korea releases winter schedule for weekly int’l flights
South Korea will expand its number of weekly flights this winter to Japan and Southeast Asia, two regions expected to have high demand that season, ...
Oct 26, 2023 (Gmt+09:00)
-
Travel & Leisure
S.Korean airlines see 12.87 mn int’l passengers in Q3 2023
South Korean airlines’ international passenger traffic in the third quarter reached 85% of that over the same period in 2019, the year befor...
Oct 19, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB gets global rights to Chinese liver cancer drug
South Korea’s HLB Therapeutics Co. on Tuesday said its US subsidiary Elevar Therapeutics has acquired the global rights excluding South Kore...
Oct 17, 2023 (Gmt+09:00)
-
Airlines
Incheon Airport’s cumulative passengers surpass 800 mn
Incheon International Airport, which opened in 2001, has surpassed a cumulative total of 800 million passengers. Incheon International Airport Corpo...
Oct 04, 2023 (Gmt+09:00)
-
E-commerce
Live commerce app Grip aims to expand into Japan, US in 2024
Imagine you're using a shopping app. You talk to the seller, ask questions and receive answers in real-time on a livestream video. Now and then, the...
Sep 20, 2023 (Gmt+09:00)
-
Airlines
Eastar Jet resumes int'l flights after three and half years
South Korea's low-cost carrier Eastar Jet on Sunday said it resumed international flights for the first time in three and a half years starting with...
Sep 04, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
LG H&H's The Whoo unveils Cheongidan renewal line in Shanghai
LG H&H Co. announced on Thursday its strategy to focus on the Chinese market by unveiling a renewal version of "Cheongidan," the flagship produc...
Aug 31, 2023 (Gmt+09:00)
-
Travel & Leisure
Foreign visitors to S.Korea in July surpass 1 mn post-COVID-19
The number of foreign tourists visiting South Korea has exceeded 1 million in a month for the first time since the outbreak of COVID-19. According t...
Aug 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to start global clinical trials for immune-oncology drug
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...
Aug 22, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience buys 6.5 million Novavax shares for $83.4 million
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...
Aug 09, 2023 (Gmt+09:00)
-
Fashion
S.Korea sees fever for luxury goods wane in post-COVID-19 era
South Korea is seeing a gradual decline in the open run, or the practice of customers standing in line before a brand's opening at a department stor...
Aug 01, 2023 (Gmt+09:00)
-
Travel & Leisure
S.Korea in June sets post-COVID-19 monthly high in foreign visitors
The (South) Korea Tourism Organization (KTO) on Friday said 961,000 foreign visitors came to the country last month, a 321.9% jump from June last ye...
Jul 28, 2023 (Gmt+09:00)
-
Airlines
S.Korea-Japan flights outpace Gimpo-Jeju in H1 2023
As Japan eased its border restrictions at the end of last year, the number of passengers on routes between South Korea and Japan in the first half o...
Jul 17, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand